Загрузка...
Cyclic-ketoximes as ER beta-selective agonists
The development of selective ERβ-agonists represents a therapeutic strategy against several kinds of cancers, but the high homology between the two receptor subtypes, ERα and ERβ, makes the achievement of this goal very challenging. In the past, we developed salicylaldoxime- and salicylketoxime-base...
Сохранить в:
| Опубликовано в: : | ChemMedChem |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4993649/ https://ncbi.nlm.nih.gov/pubmed/27135651 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cmdc.201600140 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|